Pages that link to "Q35103214"
Jump to navigation
Jump to search
The following pages link to Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma (Q35103214):
Displaying 50 items.
- MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma (Q21245768) (← links)
- Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma (Q24612429) (← links)
- Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3 (Q27670941) (← links)
- The PYRIN domain in signal transduction (Q28383855) (← links)
- Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development (Q28475285) (← links)
- Downregulation of RUNX3 and TES by hypermethylation in glioblastoma (Q33253913) (← links)
- Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells (Q33721652) (← links)
- Glioblastoma biomarkers from bench to bedside: advances and challenges (Q34103890) (← links)
- 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. (Q34374136) (← links)
- DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma (Q34498783) (← links)
- Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation. (Q34511715) (← links)
- Genomic profiling of C/EBPβ2 transformed mammary epithelial cells: A role for nuclear interleukin-1β (Q34582211) (← links)
- DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. (Q34722434) (← links)
- Methylation mediated silencing of TMS1/ASC gene in prostate cancer (Q34983345) (← links)
- SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation (Q35077092) (← links)
- DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines (Q35098017) (← links)
- DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma (Q35125867) (← links)
- Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1 (Q35190706) (← links)
- Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma (Q35783190) (← links)
- ASC deficiency suppresses proliferation and prevents medulloblastoma incidence (Q35904348) (← links)
- CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer (Q35959023) (← links)
- Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis (Q36389364) (← links)
- Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma (Q36438142) (← links)
- Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure (Q36885431) (← links)
- Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity (Q36979736) (← links)
- DNA methylation in hepatocellular carcinoma (Q37113559) (← links)
- Personalized treatment strategies in glioblastoma: MGMT promoter methylation status (Q37221207) (← links)
- Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood. (Q37229938) (← links)
- Epigenetic changes in gliomas (Q37287032) (← links)
- Epigenetic markers in human gliomas: prospects for therapeutic intervention (Q37301207) (← links)
- Inflammasomes in Myeloid Cells: Warriors Within (Q37607695) (← links)
- Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers (Q37798947) (← links)
- Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets (Q37937061) (← links)
- Prognostic markers of astrocytoma: how to predict the unpredictable? (Q38089921) (← links)
- Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function (Q38167273) (← links)
- DNA methylation and apoptosis resistance in cancer cells (Q38202821) (← links)
- NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions (Q38680628) (← links)
- The Working Modules of Long Noncoding RNAs in Cancer Cells (Q38885465) (← links)
- An update on the epigenetics of glioblastomas (Q38944047) (← links)
- Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors (Q39325094) (← links)
- Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma (Q39568502) (← links)
- DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis (Q39847607) (← links)
- Methylation-sensitive regulation of TMS1/ASC by the Ets factor, GA-binding protein-alpha. (Q39867722) (← links)
- Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells (Q40138806) (← links)
- Dual role of TMS1/ASC in death receptor signaling (Q40277157) (← links)
- Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer (Q41495469) (← links)
- Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events (Q41896356) (← links)
- Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update (Q42281992) (← links)
- Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme. (Q42588131) (← links)
- Methylation of the ASC gene promoter is associated with aggressive prostate cancer (Q46903004) (← links)